| 54.58 |  +0.63 / +1.17% |
Data as of 4:00pm ET | Day’s Change |
| 54.58 |  0.00 / 0.00% |
Volume: 5.8K |
| Previous close | 53.95 |
| Today’s open | 54.12 |
| Day’s range | 53.76 - 54.93 |
| Volume | 102,709 |
| Average volume (3 months) | 277,863 |
| Market cap | $1.9B |
| Dividend yield | -- |
| Earnings growth (last year) | -8.88% |
| Earnings growth (this year) | +6.18% |
| Earnings growth (next 5 years) | +17.00% |
| Revenue growth (last year) | +21.73% |
| P/E ratio | 89.5 |
| Price/Sales | 4.05 |
| Price/Book | 6.74 |
| Today’s change | Today’s % change | |
|---|---|---|
| ALNYAlnylam Pharmaceutic... | +0.30 | +1.01% |
| CRLCharles River Labora... | -0.65 | -1.50% |
| ICLRICON PLC | +0.28 | +0.78% |
| ISISIsis Pharmaceuticals... | +0.32 | +1.41% |
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | $0.29 |
| Annual revenue (last year) | $450.8M |
| Annual profit (last year) | $22.2M |
| Net profit margin | 4.92% |
Sector Health Services |
Industry Services to the Health Industry |
Chairman & Chief Executive Officer Robert W. Musslewhite |
President & Director David L. Felsenthal, MBA |
Corporate headquarters Washington, District Of Columbia |
.
